Artbio, a US biotech specializing in radiopharmaceuticals, has raised $132 million in a series B financing to move its lead ...

The platform elevates institutional funds into composable DeFi foundations, fostering true ecosystem-wide interoperability ...

Apellis Pharmaceuticals (Nasdaq: APLS) has received clearance from the American medicines regulator for Empaveli (pegcetacoplan) as the first treatment to reduce proteinuria in patients aged 12 and ...